-
Geriatric Nutritional Risk Index (GNRI) and Prognostic Nutritional Index (PNI) Before Treatment as the Predictive Indicators for Bone Metastasis in Prostate Cancer Patients
24 May 2025 12:50 GMT
… Metastasis, Single Bone Metastasis, and Multiple Bone Metastasis
… bone metastasis, single bone metastasis, and multiple bone metastasis.
… cancer bone metastasis.
Tumor metastasis depends on … small cell lung cancer patients with bone metastasis. Clin …
-
Verastem Oncology announces positive results from RAMP 205 evaluating avutometinib plus defactinib in combo with standard─of─care chemotherapy in frontline metastatic PDAC
24 May 2025 13:22 GMT
… front-line for patients with metastatic pancreatic ductal adenocarcinoma (PDAC … Nab-paclitaxel in frontline metastatic PDAC. In the dose … phase 3 front-line metastatic PDAC trial to begin … G12C mutant non-small cell lung cancer (RAMP 203; NCT05074810). …
-
Maintenance regimen a potential new standard in extensive-stage small cell lung cancer
23 May 2025 22:53 GMT
… extensive-stage small cell lung cancer, according to study … ‘Devastating diagnosis’
Small cell lung cancer — the most aggressive subtype … of lung cancer cases.
About 70% of small cell lung cancers are … brain or spinal cord metastases.
All trial participants …
-
Second-Line & Later Therapies Show Promising Outcomes in Small Cell Lung Cancer
23 May 2025 01:03 GMT
… therapy lines in small cell lung cancer, with best responses seen in … at ASCO 2025, small cell lung cancer (SCLC) remains a particularly difficult … 4.3 months. Notably, brain metastases, present in half of the …
-
Zepzelca, Tecentriq combo extends survival in hard-to-treat lung cancer
22 May 2025 21:20 GMT
… hard-to-treat form of lung cancer, according to clinical trial data … people with small cell lung cancer that has metastasized, and sought to show … treat people whose small cell lung cancer has progressed. The clearance was …
-
Mythic Therapeutics to Present Compelling Efficacy Data from Phase 1 KisMET-01 Study Supporting Best-in-Class Potential of Investigational cMET ADC, MYTX-011, in Non-Small Cell Lung Cancer
22 May 2025 21:03 GMT
… with non-small cell lung cancer (NSCLC) at the …
Session Name: Lung Cancer – Non-Small Cell Metastatic
Session Date and … treated, locally advanced or metastatic NSCLC. The study is … locally advanced, recurrent or metastatic NSCLC (NCT05652868).
About Mythic …
-
ASCENT-03: Trodelvy® Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors
23 May 2025 12:41 GMT
… advanced, inoperable, or metastatic triple-negative breast cancer … 90% of breast and lung cancers. Trodelvy is intentionally … Unresectable locally advanced or metastatic triple-negative breast … systemic therapies in the metastatic setting.
IMPORTANT SAFETY …
-
Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting
21 May 2025 20:28 GMT
… (ROS1+) non-small cell lung cancer (NSCLC), will be presented … ROS1+ non–small cell lung cancer across pivotal studies and between … with locally advanced or metastatic ROS1+ NSCLC who either … patients with locally advanced or metastatic ROS1+ NSCLC.
About …
-
Gene Solutions introduces AI-powered blood test for lung cancer detection in Asia
21 May 2025 10:53 GMT
… powered blood test for lung cancer detection in Asia
May … burden of lung cancer, accounting for 62% of global lung cancer deaths. … region are diagnosed at the metastatic stage, when symptoms appear … for multiple cancers, including lung cancer, in a single blood …
-
Astellas And Pfizer's XTANDITM (Enzalutamide) Shows Long-Term Overall Survival In Metastatic Hormone-Sensitive Prostate Cancer
22 May 2025 23:03 GMT
… prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer (nmCRPC … -resistant prostate cancer (CRPC)
metastatic castration-sensitive prostate cancer (mCSPC … and thoracic cancers, which includes lung cancer. Driven by science, we are …
About
© 1995-2025